tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MAYNF Stock Latest News

Mayne Pharma Faces Legal Challenges in Acquisition by Cosette Pharmaceuticals
Company AnnouncementsMayne Pharma Faces Legal Challenges in Acquisition by Cosette Pharmaceuticals
18h ago
Mayne Pharma Granted Extension for AGM Amid Acquisition Plans
PremiumCompany Announcements
Mayne Pharma Granted Extension for AGM Amid Acquisition Plans
3d ago
Mayne Pharma’s Acquisition by Cosette Pharmaceuticals Faces FIRB Approval Extension
PremiumCompany Announcements
Mayne Pharma’s Acquisition by Cosette Pharmaceuticals Faces FIRB Approval Extension
4d ago
Mayne Pharma Faces Acquisition Challenges Amid National Interest Concerns
PremiumCompany Announcements
Mayne Pharma Faces Acquisition Challenges Amid National Interest Concerns
4d ago
Mayne Pharma Awaits FIRB Approval for Acquisition Scheme
PremiumCompany Announcements
Mayne Pharma Awaits FIRB Approval for Acquisition Scheme
7d ago
Mayne Pharma Acquisition Faces Hurdles Over National Interest Concerns
PremiumCompany AnnouncementsMayne Pharma Acquisition Faces Hurdles Over National Interest Concerns
11d ago
Mayne Pharma Announces Cessation of Performance Rights
Premium
Company Announcements
Mayne Pharma Announces Cessation of Performance Rights
13d ago
UBS Group AG Ceases to be Substantial Shareholder in Mayne Pharma
Premium
Company Announcements
UBS Group AG Ceases to be Substantial Shareholder in Mayne Pharma
22d ago
Mayne Pharma Announces Cessation of Performance Rights
PremiumCompany Announcements
Mayne Pharma Announces Cessation of Performance Rights
26d ago
Mayne Pharma Faces Delay in FIRB Approval for Acquisition by Cosette Pharmaceuticals
PremiumCompany Announcements
Mayne Pharma Faces Delay in FIRB Approval for Acquisition by Cosette Pharmaceuticals
26d ago
Mayne Pharma Awaits Court Approval for Acquisition Scheme
PremiumCompany Announcements
Mayne Pharma Awaits Court Approval for Acquisition Scheme
26d ago
Mayne Pharma Wins Court Case, Advances Acquisition Scheme with Cosette
PremiumCompany Announcements
Mayne Pharma Wins Court Case, Advances Acquisition Scheme with Cosette
26d ago
Mayne Pharma’s 2025 Commitment to Accessible Medications
PremiumCompany AnnouncementsMayne Pharma’s 2025 Commitment to Accessible Medications
28d ago
Mayne Pharma Releases 2025 Corporate Governance Statement
Premium
Company Announcements
Mayne Pharma Releases 2025 Corporate Governance Statement
28d ago
Mayne Pharma Announces Cessation of Securities
Premium
Company Announcements
Mayne Pharma Announces Cessation of Securities
1M ago
Mayne Pharma’s NEXTSTELLIS® Gains PBS Listing in Australia
PremiumCompany Announcements
Mayne Pharma’s NEXTSTELLIS® Gains PBS Listing in Australia
1M ago
First Sentier Investors Ceases Substantial Holding in Mayne Pharma
PremiumCompany Announcements
First Sentier Investors Ceases Substantial Holding in Mayne Pharma
2M ago
Mayne Pharma Clarifies Position on Scheme Transaction Amid Media Speculation
PremiumCompany Announcements
Mayne Pharma Clarifies Position on Scheme Transaction Amid Media Speculation
2M ago
Mayne Pharma Reports Revenue Growth Amid Acquisition Talks
PremiumCompany Announcements
Mayne Pharma Reports Revenue Growth Amid Acquisition Talks
2M ago
Mayne Pharma Releases FY25 Financial Results
PremiumCompany AnnouncementsMayne Pharma Releases FY25 Financial Results
2M ago
Mayne Pharma Reports Strong FY25 Financial Performance with Significant EBITDA Growth
Premium
Company Announcements
Mayne Pharma Reports Strong FY25 Financial Performance with Significant EBITDA Growth
2M ago
Mayne Pharma Disputes Cosette’s Termination Notice Allegations
Premium
Company Announcements
Mayne Pharma Disputes Cosette’s Termination Notice Allegations
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >